Rchr
J-GLOBAL ID:201801011440472036   Update date: Apr. 17, 2024

Kohji Moriishi

モリイシ コウジ | Kohji Moriishi
Affiliation and department:
Job title: Professor
Other affiliations (2):
Homepage URL  (2): http://www.med.yamanashi.ac.jp/clinical_basic/microbio/http://www.med.yamanashi.ac.jp/clinical_basic/microbio/English/
Research field  (1): Virology
Research theme for competitive and other funds  (27):
  • 2020 - 2025 ウイルス-人体相互作用ネットワークの理解と制御
  • 2021 - 2022 Development of a research platform investing diagnostic, preventative, and therapeutic strategies for variant SARS-CoV-2
  • 2021 - 2022 Basic research and development of novel diagnostic and therapeutic approaches for viral hepatitis
  • 2019 - 2022 肝炎ウイルスの感染複製増殖と病原性発現を阻止するための基盤的研究とその応用のための基盤的開発
  • 2017 - 2022 新規メカニズムに基づくB型肝炎治療薬の探索
Show all
Papers (168):
  • Keigo Yato, Mami Matsuda, Kento Fukano, Tomohisa Tanaka, Kohji Moriishi, Hironori Nishitsuji, Kunitada Shimotohno, Koji Tamura, Takaji Wakita, Masamichi Muramatsu, et al. Identification of neutralizing epitopes in the preS2 domain of the hepatitis B virus. Virus research. 2023. 323. 199014-199014
  • Ayaka Washizaki, Asako Murayama, Megumi Murata, Tomoko Kiyohara, Keigo Yato, Norie Yamada, Hussein Hassan Aly, Tomohisa Tanaka, Kohji Moriishi, Hironori Nishitsuji, et al. Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen. Nature Communications. 2022. 13. 1
  • Takashi Okura, Kazuya Shirato, Masatoshi Kakizaki, Satoko Sugimoto, Shutoku Matsuyama, Tomohisa Tanaka, Yohei Kume, Mina Chishiki, Takashi Ono, Kohji Moriishi, et al. Hydrophobic Alpha-Helical Short Peptides in Overlapping Reading Frames of the Coronavirus Genome. Pathogens. 2022. 11. 8. 877-877
  • Masaaki Toyama, Koichi Watashi, Masanori Ikeda, Atsuya Yamashita, Mika Okamoto, Kohji Moriishi, Masamichi Muramatsu, Takaji Wakita, Ashoke Sharon, Masanori Baba. Novel Neplanocin A Derivatives as Selective Inhibitors of Hepatitis B Virus with a Unique Mechanism of Action. Antimicrobial Agents and Chemotherapy. 2022
  • Yoichi Miyamoto, Yumi Itoh, Tatsuya Suzuki, Tomohisa Tanaka, Yusuke Sakai, Masaru Koido, Chiaki Hata, Cai-Xia Wang, Mayumi Otani, Kohji Moriishi, et al. SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication. Communications biology. 2022. 5. 1. 483-483
more...
MISC (20):
more...
Patents (1):
  • 細胞株及びその作製方法
Books (2):
  • シンプル微生物学
    南江堂 2018 ISBN:9784524254835
  • 人獣共通感染症(改訂三版)
    医薬ジャーナル 2016
Lectures and oral presentations  (37):
  • Regulatory mechanism of polycomb suppressive complex 1 activity by HCV infection
    (第68回 日本ウイルス学会総会 2021)
  • Cross-species transmission of rat hepacivirus and its adaptation to mouse.
    (第68回 日本ウイルス学会総会 2021)
  • Identification of antiviral agents targeting HBV Enhancer I-X promoter
    (第68回 日本ウイルス学会総会 2021)
  • Transient and stable replicon systems of SARS-CoV-2 for drug screening
    (第68回 日本ウイルス学会総会 2021)
  • HCV infection impairs monoubiquitination of histone H2A via proteolysis of RNF2 and activates expression of HOX genes
    (19th Awaji International Forum on Infection and Immunity 2021)
more...
Professional career (4):
  • Master of Veterinary Medicine (Hokkaido University)
  • 修士(獣医学) (北海道大学大学院)
  • Ph. D. (Veterinary Medicine) (Hokkaido University)
  • 博士(獣医学) (北海道大学大学院)
Committee career (7):
  • 2016/04 - 現在 日本ウイルス学会 評議委員
  • 2020/04/01 - 2021/03/31 韮崎高校 スパーサイエンスハイスクール 評価委員会 外部評価委員
  • 2019/04/01 - 2020/03/31 日本ウイルス学会 理事
  • 2019/04/01 - 2020/03/31 日本ウイルス学会 評議員
  • 2017/04/01 - 2019/03/31 日本ウイルス学会 理事
Show all
Association Membership(s) (2):
日本分子生物学会 ,  日本ウイルス学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page